Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran

Recently two novel enzymes were identified in the outer mitochondrial membrane, mARC1 and mARC2. These molybdenum containing enzymes can reduce a variety of N-hydroxylated compounds, such as N-hydroxy-guanidines and sulfohydroxamic acids, as well as convert nitrite into nitric oxide (NO). However, t...

Full description

Bibliographic Details
Main Authors: Neve, Etienne P. A., Köfeler, Harald, Hendriks, Delilah F. G., Nordling, Åsa, Gogvadze, Vladimir, Mkrtchian, Souren, Näslund, Erik, Ingelman-Sundberg, Magnus
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574727/
id pubmed-4574727
recordtype oai_dc
spelling pubmed-45747272015-09-25 Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran Neve, Etienne P. A. Köfeler, Harald Hendriks, Delilah F. G. Nordling, Åsa Gogvadze, Vladimir Mkrtchian, Souren Näslund, Erik Ingelman-Sundberg, Magnus Research Article Recently two novel enzymes were identified in the outer mitochondrial membrane, mARC1 and mARC2. These molybdenum containing enzymes can reduce a variety of N-hydroxylated compounds, such as N-hydroxy-guanidines and sulfohydroxamic acids, as well as convert nitrite into nitric oxide (NO). However, their endogenous functions remain unknown. Here we demonstrate a specific developmental pattern of expression of these enzymes. mARC1, but not mARC2, was found to be expressed in fetal human liver, whereas both, in particular mARC2, are abundant in adult liver and also expressed in omental and subcutaneous fat. Caloric diet restriction of obese patients caused a decreased expression of mARC2 in liver, similar to that seen in the livers of starved rats. Knock down of mARC2 expression by siRNA in murine adipocytes had statistically significant effect on the level of diglycerides and on the fatty acid composition of some triglycerides, concomitantly a clear trend toward the reduced formation of most of triglyceride and phospholipid species was observed. The involvement of mARC2 in the metabolism of the hepatotoxic drug ximelagatran was evaluated in hepatocytes and adipocytes. Ximelagatran was shown to cause oxidative stress and knock down of mARC2 in adipocytes prevented ximelagatran induced inhibition of mitochondrial respiration. In conclusion, our data indicate that mARC1 and mARC2 have different developmental expression profiles, and that mARC2 is involved in lipogenesis, is regulated by nutritional status and responsible for activation of ximelagatran into a mitotoxic metabolite(s). Public Library of Science 2015-09-17 /pmc/articles/PMC4574727/ /pubmed/26378779 http://dx.doi.org/10.1371/journal.pone.0138487 Text en © 2015 Neve et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Neve, Etienne P. A.
Köfeler, Harald
Hendriks, Delilah F. G.
Nordling, Åsa
Gogvadze, Vladimir
Mkrtchian, Souren
Näslund, Erik
Ingelman-Sundberg, Magnus
spellingShingle Neve, Etienne P. A.
Köfeler, Harald
Hendriks, Delilah F. G.
Nordling, Åsa
Gogvadze, Vladimir
Mkrtchian, Souren
Näslund, Erik
Ingelman-Sundberg, Magnus
Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran
author_facet Neve, Etienne P. A.
Köfeler, Harald
Hendriks, Delilah F. G.
Nordling, Åsa
Gogvadze, Vladimir
Mkrtchian, Souren
Näslund, Erik
Ingelman-Sundberg, Magnus
author_sort Neve, Etienne P. A.
title Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran
title_short Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran
title_full Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran
title_fullStr Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran
title_full_unstemmed Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran
title_sort expression and function of marc: roles in lipogenesis and metabolic activation of ximelagatran
description Recently two novel enzymes were identified in the outer mitochondrial membrane, mARC1 and mARC2. These molybdenum containing enzymes can reduce a variety of N-hydroxylated compounds, such as N-hydroxy-guanidines and sulfohydroxamic acids, as well as convert nitrite into nitric oxide (NO). However, their endogenous functions remain unknown. Here we demonstrate a specific developmental pattern of expression of these enzymes. mARC1, but not mARC2, was found to be expressed in fetal human liver, whereas both, in particular mARC2, are abundant in adult liver and also expressed in omental and subcutaneous fat. Caloric diet restriction of obese patients caused a decreased expression of mARC2 in liver, similar to that seen in the livers of starved rats. Knock down of mARC2 expression by siRNA in murine adipocytes had statistically significant effect on the level of diglycerides and on the fatty acid composition of some triglycerides, concomitantly a clear trend toward the reduced formation of most of triglyceride and phospholipid species was observed. The involvement of mARC2 in the metabolism of the hepatotoxic drug ximelagatran was evaluated in hepatocytes and adipocytes. Ximelagatran was shown to cause oxidative stress and knock down of mARC2 in adipocytes prevented ximelagatran induced inhibition of mitochondrial respiration. In conclusion, our data indicate that mARC1 and mARC2 have different developmental expression profiles, and that mARC2 is involved in lipogenesis, is regulated by nutritional status and responsible for activation of ximelagatran into a mitotoxic metabolite(s).
publisher Public Library of Science
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574727/
_version_ 1613477135275524096